Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics
- 1 June 1982
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 43 (2-3), 321-327
- https://doi.org/10.1016/0021-9150(82)90032-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid estersAtherosclerosis, 1980
- The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrateAtherosclerosis, 1980
- One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- Plasma High-Density LipoproteinsNew England Journal of Medicine, 1978
- High density lipoprotein distributionAtherosclerosis, 1978
- The effect of treatment with clofibrate on hepatic triglyceride and lipoprotein lipase activities of post heparin plasma in male patients with hyperlipoproteinemiaAtherosclerosis, 1977
- Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin levelArchives of Internal Medicine, 1972
- Precipitation des alpha lipoproteines du serum par le phosphotungstate de sodium en presence du chlorure de magnesiumLife Sciences, 1969
- IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MANJournal of Clinical Investigation, 1960